Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic Rats by Zhenwen Zhang, Penghua Fang, Biao He, Lili Guo, Johan Runesson, Ülo Langel, Mingyi Shi, Yan Zhu, Ping Bo

“…Our previous studies testified the beneficial effect of central galanin on insulin sensitivity of type 2 diabetic rats. The aim of the study was further to investigate whether central M617, a galanin receptor 1 agonist, can benefit insulin sensitivity. …”
Get full text

102 Jurnal Kesehatan Andalas. 2015; 4(1) Pola Komplikasi Kronis Penderita Diabetes Melitus Tipe 2 Rawat Inap di Bagian Penyakit Dalam RS. Dr. M. Djamil Padang Januari 2011 - Desemb... by Dwi Amelisa Edwina, Asman Manaf, Efrida .

“…The objective of this study was to obtain a picture of the incidence of type 2 diabetic chronic complications. This descriptive study was conducted by taking medical record data of hospitalized type 2 diabetic patients with chronic complications inInternal Medicine Department Dr. …”
Get full text

PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice by Ying Sun, Zhanjun Jia, Gang Liu, Li Zhou, Mi Liu, Baoxue Yang, Tianxin Yang

“…Collectively, the present study demonstrated an inhibitory effect of PPARγ activation on renal mPGES-1/PGE2/EP4 pathway in type-2 diabetes and suggested that mPGES-1 may potentially serve as a therapeutic target for treating type-2 diabetes-associated DN.…”
Get full text

Quality of life related to age and economic income in diabetic older adults. Chillan, Chile, 2019 by David Isaac Caamaño Valderrama, Claudia Andrea Concha Navarro, Yocelin Belén Del Canto Celis, Gustavo Alberto Dupré Orias, Ismael Morales Ojeda, Paulina Segura Hernández

“…<br /><strong>Objective</strong>: to determine the relationship between quality of life, age and income in older adults with type 2 diabetes mellitus.<br /><strong>Methods</strong>: a descriptive, cross-sectional study was carried out in 33 older adults with type 2 diabetes mellitus, selected by non-probabilistic convenience sampling, in the Las Mariposas community (Chillán, Chile), in 2019. …”
Get full text

Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy by Satu Vavuli, Tuire Salonurmi, Sirpa Loukovaara, Antti E. Nissinen, Markku J. Savolainen, M. Johanna Liinamaa

“…There were no differences in IgG, IgM, or IgA that would be specific for DR or for DME. Type 2 diabetic patients had higher levels of IgA autoantibodies than type 1 diabetic patients (86.0 and 65.5, resp., p=0.004) and the highest levels in IgA were found in type 2 diabetic patients with PDR (119.1, p>0.001). …”
Get full text

Testosterone Deficiency, Cardiac Health, and Older Men by G. Hackett, M. Kirby, A. J. Sinclair

“…The prevalence rates of testosterone deficiency vary according to different studies but may be as high as 40% in populations of patients with type 2 diabetes. There is increasing evidence that testosterone deficiency is associated with increased cardiovascular and all-cause mortality. …”
Get full text

Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease by Gene P. Ables

“…Insulin resistance is one of the characteristics of type 2 diabetes. Several types of treatment have been employed against type 2 diabetes some of which ameliorate NAFLD. …”
Get full text

The assessment of the facial skin microbiota in patients with seborrheic dermatitis and metabolic syndrome by Kristina Yu. Molodykh, Elena R. Araviiskaia, Evgeny V. Sokolovskiy, Lyudmila A. Kraeva

“…In recent years, data have emerged indicating a direct link between changes in the composition of the skin microbiota and obesity, as well as related diseases, primarily type 2 diabetes mellitus. The aims. To give a clinical and microbiological characteristic of seborrheic dermatitis of the face in persons with metabolic syndrome and type 2 diabetes mellitus and in persons without concomitant pathology. …”
Get full text

The influence of gender and waist circumference in the association of body fat with cardiometabolic diseases by Milad Bagheri, Mehran Nouri, Ali Kohanmoo, Reza Homayounfar, Masoumeh Akhlaghi

“…Information on demographic and lifestyle factors, and history of cardiometabolic diseases (metabolic syndrome, type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and myocardial infarction) was obtained. …”
Get full text

Risk Factors and Consequent Diseases of Atherosclerosis in a Population Treated in a Medical Office by Luis Ángel Felicó Riverón, Georgia Díaz-Perera Fernández, Yomeidis Felicó Riverón

“…Overweight and obesity has the highest risk associated with altered waist circumference; arterial hypertension with type 2 diabetes mellitus; dyslipidemia with family history of dyslipidemia; and type 2 diabetes mellitus with dyslipidemia and with a family history of type 2 diabetes mellitus. …”
Get full text

Diabetic Cataract in Spontaneously Diabetic Torii Fatty Rats by Kasumi Kikuchi, Miyuki Murata, Kousuke Noda, Satoru Kase, Yoshiaki Tagawa, Yasushi Kageyama, Masami Shinohara, Tomohiko Sasase, Susumu Ishida

“…Spontaneously Diabetic Torii (SDT) fatty rat is a novel animal model of type 2 diabetes with obesity. SDT fatty rats develop hyperglycemia, dyslipidemia, and other diabetic complications including ocular disorders; however, diabetic cataract formation in SDT fatty rats has not been fully investigated. …”
Get full text

An Exceedingly Rare Case of Liraglutide-Induced Liver Injury by Swetha Parvataneni, Rajarajeshwari Ramachandran, Eric Then, Tyler Grantham, Vinaya Gaduputi

“…Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.…”
Get full text

The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment by Yi-Cheng Chang, Siow-Wey Hee, Meng-Lun Hsieh, Yung-Ming Jeng, Lee-Ming Chuang

“…The type 2 diabetes pandemic in recent decades is a huge global health threat. …”
Get full text

Sodium-Glucose Transport Protein 2 Inhibitors Association with Euglycemic Diabetic Ketoacidosis by Caroline Wojtas, Alex P. Rasarmos, Naja Naddaf

“…Diabetic ketoacidosis (DKA) is a life-threatening medical emergency that occurs in both type 1 and type 2 diabetes mellitus. Here, we describe the case of a 49 year-old male patient with type 2 diabetes mellitus who presented to the emergency department with complaints of epigastric abdominal pain and intractable vomiting. …”
Get full text

Health literacy in context: struggling to self-manage diabetes – a longitudinal qualitative study by Xavier Debussche, Maryvette Balcou-Debussche, Delphine Ballet, Jessica Caroupin-Soupoutevin

“…The purpose of this qualitative study was to provide a detailed analysis of the health literacy of people with type 2 diabetes in relation to their daily self-care practices.Design Nested qualitative study in the ERMIES randomised controlled trial testing a 2-year structured care in type 2 diabetes. …”
Get full text

Characterization of Ischemic Cerebrovascular Disease in Diabetic Patients at the General Calixto García Clinical Surgical University Hospital by Yunier Angarica Aguilar, Jorge Félix Salazar Rodríguez, Damaris Herrera Arrebato, Emelina Despaigne Carrión, María de los Ángeles Hechevarría Heredia, César Emilio Reina Rodríguez

“…In the Americas they constitute the third cause of death and their incidence is increased in type 2 diabetic patients. <br /><strong>Objective:</strong> to characterize type 2 diabetic patients with acute ischemic cerebrovascular disease. …”
Get full text

Metformin-Associated Acute Kidney Injury and Lactic Acidosis by David Arroyo, Rosa Melero, Nayara Panizo, Marian Goicoechea, Patrocinio Rodríguez-Benítez, Soledad García Vinuesa, Eduardo Verde, Alberto Tejedor, José Luño

“…Metformin is the preferred oral antidiabetic agent for type 2 diabetes. Lactic acidosis is described as a rare complication, usually during an acute kidney injury (AKI). …”
Get full text

Therapeutic Potential of Retinoid X Receptor Modulators for the Treatment of the Metabolic Syndrome by Jane A. Pinaire, Anne Reifel-Miller

“…These compounds have glucose-lowering, insulin-sensitizing, and antiobesity effects in animal models of insulin resistance and type 2 diabetes. However, undesirable side effects such as hypertriglyceridemia and suppression of the thyroid hormone axis also occur. …”
Get full text

Reduced TCA Flux in Diabetic Myotubes: Determined by Single Defects? by Michael Gaster

“…ATP production was measured by luminescence with or without concomitant ATP utilisation by hexokinase in mitochondria isolated from myotubes established from eight lean and eight type 2 diabetic subjects. The ATP production of investigated substrate combinations was significantly reduced in mitochondria isolated from type 2 diabetic subjects compared to lean. …”
Get full text

Relationships of Adrenoceptor Polymorphisms with Obesity by Kazuko Masuo, Gavin W. Lambert

“…Obesity, hypertension, and type 2 diabetes are rapidly growing public health problems. …”
Get full text